CLOV vs JBIO · rev $1.37B vs $868.2M cap
Clover Health Investments Corp (CLOV) versus Jade Biosciences, Inc. (JBIO) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Jade Biosciences, Inc. (JBIO) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
JBIO does not have a complete income-statement cache yet.
CLOV currently screens at market cap $1.55B. JBIO currently screens at market cap $868.2M.
Not investment advice. Open the CLOV and JBIO stock pages for the full models.
Not investment advice.